An observational study in Dementia, Abuse Client and Neglect; Care, Malnutrition, sponsored by University of Manchester. Completed at 5 sites in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-26.
Sponsored by University of Manchester · Observational
Maharani A, Dixon J, Szulewska K, Robinson C, Cooper M, Panagioti M, Blakeman T, Lasrado R. Geographical and temporal distribution of safeguarding concerns amo…PubMed 42648775 ↗; 1 more
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 178 studies in Dementia with a site in United Kingdom — 39 open to participants now, 58 under way, 12 of them phase 3. Dementia · United Kingdom.
Among the 178 studies in Dementia with a site in United Kingdom, this one is the 45th largest by enrollment of the 54 observational ones that give a count, is one of 14 that started in 2023, is one of 54 observational ones, and was the 133rd registered.
2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.
Browse Dementia studies →39 of the 178 studies in Dementia with a site in United Kingdom are open now. Recruiting first, the newest first:
University College, London · Sites in United Kingdom
Ages 55+
Bristol-Myers Squibb · Sites in United Kingdom, United States, Australia and 2 more countries
Ages 55–90
Northumbria Healthcare NHS Foundation Trust · Sites in United Kingdom
Ages 65+
Exciva GmbH · Sites in United Kingdom, United States, Canada and 6 more countries
Ages 55–90
University of Nottingham · Sites in United Kingdom
Ages 18–99 · Healthy volunteers
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
178 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 34 · Phase 3 40 · Phase 4 3
First in 1999; this study’s year is marked. 14 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 37 is below the median of 252 across 554 observational studies indexed under Dementia.
Median enrollment 196 across the 124 interventional studies, 210 across the 54 observational. Of the 94 that completed or were terminated, 27 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
57 of 178 have an industry lead sponsor. The 10 most frequent:
University of Manchester is the lead sponsor of 201 studies on the registry; 44 are open to participants now.
University of Manchester has 2 studies filed under Dementia — fewer than ten, so there is no comparison to draw.
9 of the studies in Dementia with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06268886Bristol-Myers SquibbStudy to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease | 2026-12-17 |
| NCT07347431Northumbria Healthcare NHS Foundation TrustLarge Language Model for Understanding and Monitoring Elderly Neurocognition | 2026-12-31 |
| NCT03507257Indiana UniversityLongitudinal Early-onset Alzheimer's Disease Study Protocol | 2027-01-01 |
| NCT06263920Lancashire Teaching Hospitals NHS Foundation TrustNeurofrailty: A Study of Late-onset Epilepsy and Its Associations | 2027-01-12 |
| NCT06937541University of West LondonFamily Interventions iN Dementia Mental Health Environments | 2027-03-31 |
Add all 9 to your calendar (.ics) → With an account.
Among the 178 studies in Dementia with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
"Adult safeguarding is everyone's responsibility". The Care Act 2014 makes safeguarding a legal duty. It provides local authorities and other agencies in England with a responsibility to protect adults with care and support needs from abuse and neglect. This is done most effectively when all relevant agencies work together. This is particularly important for people living with dementia, as they are at higher risk of abuse or neglect. Such abuse is most common in their own homes and care settings. Primary and social care professionals are likely to have regular contacts with older people, hence have opportunities for early identification and prevention of abuse. However, little is known about how primary care practitioners work in partnership with social care and other agencies to investigate and manage abuse.
Aims:
This project will outline how health professionals in primary care settings understand and respond to abuse and what their understandings of safeguarding law and policy are. It will also identify how social services departments assess and manage referrals relating to people living with dementia in primary care settings. Furthermore, the study will analyse the experiences of people with dementia and families who are at the centre of safeguarding
Methods:
This study has three phases. In phase 1, the investigators will synthesise current research and practice evidence to develop a theory of safeguarding conceptualisation and process. In phase 2, the investigators will analyse national statistics on safeguarding (NHS digital dataset), ageing and dementia data (English Longitudinal Study of Ageing) to understand patterns of reporting and how they vary across location, gender, ethnicity and time period. In phase 3, the investigators will interview GPs, social workers, safeguarding leads, independent advocates, people with dementia, family members, support workers, carers and other professionals who make or receive referrals via primary care. As part of phase 3 group discussions will also be conducted, in which professionals will come together to share their experiences, and will identify approaches for preventing abuse and collaboration amongst relevant agencies. Phase 3 will inform the development of complex case studies, drawing on data from phases 1 and 2.
Impact:
This study will help develop practice guidance for professionals, to aid multi-agency collaboration in safeguarding cases specific to dementia. This will be developed in consultation with the PPIE (Patient and Public Involvement and Engagement) members and practitioners. Videos will also be produced and plain English versions of case studies of complex safeguarding scenarios and strategies in consultation with safeguarding leads, law experts, training providers and other key stakeholders. Experts by experience (working with, caring for or living with dementia), will be able to guide the team with cultural nuances and appropriateness to ensure that the material developed is sensitive to all populations. An info graph/pictograph displaying signs of abuse, staying safe and what to do, aimed at people with dementia and family will be compiled. The investigators will liaise with national safeguarding leads so that this information can be displayed in GP clinics. Furthermore, the investigators will contact social responsibility personnel for supermarkets and discuss the potentials of wider circulation for displaying this information in stores.
Tentatively this study will aim to recruit 20-30 health and social care professionals (interviews-20, focus groups-10) making referrals via GP's who have experiences of safeguarding in the context of dementia. This study also aims to recruit between 15-20 people with dementia and carers/family members involved in safeguarding, who will be accessed via primary and social care practitioners.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Health and social care professionals:
Service users and carers/family:
Exclusion Criteria:
Health and social care professionals at GP practices, social care organisations and third sector organisations without experiences of safeguarding older adults and unwilling to participate in the study.
GP's, nurses, social workers, mental health professionals, support workers, Independent mental capacity advocates (IMCA), and other HCP's working in GP surgeries and integrated social care hubs. Safeguarding leads in GP surgeries, social care organisations and other relevant organisations. Professionals from third-sector organisations who have previous experience of safeguarding.
Other: Not applicable as not an intervention - HCP's
Who have been involved in the safeguarding process and have capacity to consent.
Other: Not applicable as not an intervention - PLwD and family/carers
Who have been involved in the safeguarding process.
Other: Not applicable as not an intervention - PLwD and family/carers
Who have been involved in the safeguarding process.
Other: Not applicable as not an intervention - PLwD and family/carers
Exploring the safeguarding process through interviews.
Exploring the safeguarding process through interviews and a focus group.
Trends in reporting of routinely collected safeguarding datasets - NHS digital
Number of reports of safeguarding concerns and section 42 enquiries in England. Type of risks, source of risks, location, age, gender, ethnicity, health condition.
Time frame: September 2022 - March 2024
Trends in reporting of routinely collected safeguarding datasets - ELSA data
The prevalence of dementia across England, number of older people with dementia in receipt of care and who gave the care in each local authority in England.
Time frame: data years: 2002-2017
Quality Outcomes Framework (QOF) Recorded Dementia Diagnoses
Rate of dementia diagnosis in each local authority district in England and demographic characteristics of those with dementia diagnosis in each NHS CCG in England.
Time frame: data years: 2021-2022
Contexts, Mechanisms and Outcomes (CMO's) from the Rapid Realist Literature Review
The rapid realist review will investigate how health \& social care professionals conceptualise and respond to risks of abuse and neglect involving people with dementia in England, UK. The review will be informed by Rameses guidelines and aims to develop initial programme theories.
Time frame: September 2022 - March 2024
Interpretative Phenomenological Analysis (IPA) of Interviews
IPA of interview transcripts will lead to an in-depth understanding of the lived experiences of safeguarding from the perspective of health and social care professionals, people living with dementia, family caregivers and other relevant professionals.
Time frame: September 2022 - March 2024
Interpretative Phenomenological analysis (IPA) of Focus Group - with health and care professionals
Lived experiences of safeguarding from the perspective of various professionals, including what worked, what did not work, understanding of legal thresholds, strategies for prevention and collaboration across agencies.
Time frame: September 2022 - March 2024
Plan to share: Undecided
Ran from May 2023 to primary completion in Feb 2024, 9 months.
Primary completion moved once since we started tracking on Sep 25, 2026: Aug 2023 → Feb 2024, on Oct 26, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
Maharani A, Dixon J, Szulewska K, Robinson C, Cooper M, Panagioti M, Blakeman T, Lasrado R. Geographical and temporal distribution of safeguarding concerns amo…PubMed 42648775 ↗; 1 more
Maharani A, Dixon J, Szulewska K, Robinson C, Cooper M, Panagioti M, Blakeman T, Lasrado R. Geographical and temporal distribution of safeguarding concerns amo…PubMed 42648775 ↗; 1 more
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.